Skip to Main Content

Paper Details

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.
Neoplasia
6
2023
DRD2, Dopamine, Dopamine receptor, Dopamine receptor D2, GBM, MET, ONC201, TRAIL receptor, TRAIL receptors, cancer, cancers, death receptor 4/5, dopamine, dopamine receptor, dopamine receptor D2, glioblastoma, glioblastoma (GBM, glioblastoma (GBM) stem-like cells, human, human GBM patient-derived tumors, patient, tumor
Author NameAffiliation
Yong Jae ShinCancer Stem Cell Research Center, Samsung Biomedical Research Institute
Kyeung Min JooCancer Stem Cell Research Center, Samsung Biomedical Research Institute
Jin-Ku LeeSeoul National University, College of Medicine
Jason K SaCancer Stem Cell Research Center, Samsung Biomedical Research Institute
Jong Bae ParkNational Cancer Center
Do-Hyun NamCancer Stem Cell Research Center, Samsung Biomedical Research Institute
Do-Hyun NamCancer Stem Cell Research Center, Samsung Biomedical Research Institute
Jeongwu LeeLerner Research Institute, Cleveland Clinic
  • 1 - 8

Datasets

Release 1.2